Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
出版年份 2015 全文链接
标题
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
作者
关键词
-
出版物
EUROPACE
Volume 17, Issue 10, Pages 1467-1507
出版商
Oxford University Press (OUP)
发表日期
2015-09-01
DOI
10.1093/europace/euv309
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF)
- (2015) Gregory Y.H. Lip et al. AMERICAN HEART JOURNAL
- Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
- (2015) Christopher B. Granger et al. AMERICAN HEART JOURNAL
- Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
- (2015) Bernhard M. Kaess et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
- (2015) An S. De Vriese et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study
- (2015) Vanessa Roldán et al. AMERICAN JOURNAL OF MEDICINE
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation
- (2015) Peter Brønnum Nielsen et al. CHEST
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE
- (2015) Alvaro Avezum et al. CIRCULATION
- Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation
- (2015) D. A. Lane et al. CIRCULATION
- Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE
- (2015) Peter Brønnum Nielsen et al. CIRCULATION
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
- (2015) Andres Enriquez et al. EUROPACE
- Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
- (2015) Giuseppe Boriani et al. EUROPACE
- Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
- (2015) R. R.-Y. Abumuaileq et al. EUROPACE
- The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists
- (2015) L. Fauchier et al. EUROPACE
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
- (2015) Deirdre A. Lane et al. EUROPACE
- Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
- (2015) Christian Sticherling et al. EUROPACE
- Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
- (2015) B. Vrijens et al. EUROPACE
- Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
- (2015) J. Steffel et al. EUROPEAN HEART JOURNAL
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
- (2015) Luigi Di Biase et al. HEART RHYTHM
- Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer
- (2015) Melina Verso et al. Internal and Emergency Medicine
- Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
- (2015) Joji B. Kuramatsu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The contribution of apixaban renal clearance to total clearance
- (2015) Charles Frost et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
- (2015) Stephan Glund et al. LANCET
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Interventional Thrombectomy for Major Stroke — A Step in the Right Direction
- (2015) Werner Hacke NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
- (2015) Tudor G. Jovin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
- (2015) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists
- (2015) Vicente Bertomeu et al. THROMBOSIS AND HAEMOSTASIS
- Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab
- (2015) Markus Honickel et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
- (2015) Thomas Marbury et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
- (2015) Franziska Ebertz et al. THROMBOSIS AND HAEMOSTASIS
- Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
- (2015) Samuel Z. Goldhaber et al. THROMBOSIS AND HAEMOSTASIS
- Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease
- (2015) Pascal Vranckx et al. THROMBOSIS AND HAEMOSTASIS
- Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen—Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study
- (2014) K. Anette Fiedler et al. AMERICAN HEART JOURNAL
- Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2014) Madan Raj Aryal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation
- (2014) Partha Sardar et al. AMERICAN JOURNAL OF CARDIOLOGY
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
- (2014) B. Gyurkocza et al. BLOOD
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran
- (2014) Bartlomiej Getta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent
- (2014) Mandy N. Lauw et al. CANADIAN JOURNAL OF CARDIOLOGY
- Non-Vitamin K Antagonist Oral Anticoagulants
- (2014) Gregory Y.H Lip et al. CHEST
- Relationship of the SAMe-TT 2 R 2 Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation
- (2014) Gregory Y.H. Lip et al. CHEST
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
- (2014) Morten Lamberts et al. CIRCULATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. CIRCULATION
- One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
- (2014) Andrea Rubboli et al. CLINICAL CARDIOLOGY
- Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
- (2014) Peter Brønnum Nielsen et al. Clinical Research in Cardiology
- Best Practice for Atrial Fibrillation Patient Education
- (2014) Deirdre Lane et al. CURRENT PHARMACEUTICAL DESIGN
- Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
- (2014) Bulent Gorenek et al. EUROPACE
- Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
- (2014) Morten Lock Hansen et al. EUROPACE
- Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations
- (2014) J. Kosiuk et al. EUROPACE
- Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey
- (2014) T. S. Potpara et al. EUROPACE
- Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
- (2014) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
- (2014) Günter Breithardt et al. EUROPEAN HEART JOURNAL
- Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- What is ‘valvular’ atrial fibrillation? A reappraisal
- (2014) Raffaele De Caterina et al. EUROPEAN HEART JOURNAL
- Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial
- (2014) Benjamin A. Steinberg et al. HEART RHYTHM
- European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2014) Thorsten Steiner et al. International Journal of Stroke
- Proposed Approach to Thrombolysis in Dabigatran-Treated Patients Presenting with Ischemic Stroke
- (2014) Mahesh Kate et al. Journal of Stroke & Cerebrovascular Diseases
- Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation
- (2014) Christian T. Ruff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2014) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation
- (2014) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL
- (2014) Michael D. Ezekowitz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
- (2014) Anders Nissen Bonde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
- (2014) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
- (2014) Adeel Shahzad et al. LANCET
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
- (2014) Jack E. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
- (2014) TOMOYUKI NAGAO et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
- (2014) Torben Bjerregaard Larsen et al. PLoS One
- Response to Ansell et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”
- (2014) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Stroke prevention in atrial fibrillation: An Asian perspective
- (2014) Kang-Ling Wang et al. THROMBOSIS AND HAEMOSTASIS
- Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?
- (2014) Graeme J. Hankey Current Cardiology Reports
- Safety of Continuous Anticoagulation With Dabigatran During Implantation of Cardiac Rhythm Devices
- (2013) Christopher P. Rowley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of Atrial Fibrillation in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] Trial)
- (2013) A. Garvey Rene et al. AMERICAN JOURNAL OF CARDIOLOGY
- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects
- (2013) Xiaoli Wang et al. American Journal of Cardiovascular Drugs
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. American Journal of Cardiovascular Drugs
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis
- (2013) Mohammed Shurrab et al. CANADIAN JOURNAL OF CARDIOLOGY
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- “R” for “Renal” and for “Risk”
- (2013) A. John Camm et al. CIRCULATION
- Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
- (2013) Ammar Majeed et al. CIRCULATION
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature
- (2013) Stefan H. Hohnloser et al. EUROPACE
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Should catheter atrial fibrillation ablation be considered as a 'high bleeding risk' intervention?
- (2013) S.-S. Bun et al. EUROPACE
- Author reply
- (2013) H. Heidbuchel et al. EUROPACE
- Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis
- (2013) Aref A. Bin Abdulhak et al. EUROPACE
- EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†
- (2013) Hein Heidbuchel et al. EUROPEAN HEART JOURNAL
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2013) J. H. Alexander et al. EUROPEAN HEART JOURNAL
- A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice
- (2013) Dana Berti et al. EUROPEAN HEART JOURNAL
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
- (2013) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
- (2013) Rui Providência et al. HEART
- Cardiovascular Implantable Electronic Device Implantation with Uninterrupted Dabigatran: Comparison to Uninterrupted Warfarin
- (2013) JOHN M. JENNINGS et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects
- (2013) D Kubitza et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis
- (2013) M. T. C. Poon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
- (2013) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
- (2013) C. Michael Gibson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
- (2013) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage
- (2013) S. Horstmann et al. NEUROLOGY
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
- (2013) David H. Birnie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood
- (2013) Gines Escolar et al. PLoS One
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
- (2013) Christian Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Patient outcomes using the European label for dabigatran
- (2013) Andreas Clemens et al. THROMBOSIS AND HAEMOSTASIS
- A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
- (2013) Pascal Vranckx et al. EuroIntervention
- Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients
- (2012) François Laliberté et al. ADVANCES IN THERAPY
- Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
- (2012) Joanne van Ryn et al. AMERICAN JOURNAL OF MEDICINE
- Safe Use of Hemodialysis for Dabigatran Removal before Cardiac Surgery
- (2012) Matthew R Wanek et al. ANNALS OF PHARMACOTHERAPY
- Dabigatran Association With Higher Risk of Acute Coronary Events
- (2012) Ken Uchino ARCHIVES OF INTERNAL MEDICINE
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
- (2012) F. Baudo et al. BLOOD
- Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Abstracts From the Emerging Science Series, June 20, 2012
- (2012) CIRCULATION
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
- (2012) Stefan H. Hohnloser et al. CIRCULATION
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation
- (2012) Jonathan P. Piccini et al. CIRCULATION
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction
- (2012) Dimitrios Alexopoulos et al. Circulation-Cardiovascular Interventions
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
- (2012) Stephen Andrew LaHaye et al. EUROPEAN HEART JOURNAL
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
- (2012) J. M. L. Hendriks et al. EUROPEAN HEART JOURNAL
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
- (2012) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
- (2012) I. PRAGST et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
- (2012) Robert G. Hart et al. STROKE
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
- (2012) Raphael Marlu et al. THROMBOSIS AND HAEMOSTASIS
- Impact of dabigatran on a large panel of routine or specific coagulation assays
- (2012) Séverine Robert et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories
- (2011) Terrence F. Blaschke et al. Annual Review of Pharmacology and Toxicology
- Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis
- (2011) Pierre Sié et al. Archives of Cardiovascular Diseases
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
- (2011) Rangadham Nagarakanti et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial Fibrillation
- (2011) W. C. Winkelmayer et al. Clinical Journal of the American Society of Nephrology
- Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
- (2011) R. G. Hart et al. Clinical Journal of the American Society of Nephrology
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
- (2011) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban
- (2011) Kenneth Todd Moore et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin
- (2011) Joachim Stangier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
- (2011) Ricarda Marinigh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
- (2011) M. LEVI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
- (2011) Chiara Marchesi et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Warfarin Use and Outcomes in Patients with Atrial Fibrillation Complicating Acute Coronary Syndromes
- (2010) Renato D. Lopes et al. AMERICAN JOURNAL OF MEDICINE
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?
- (2010) J. W. McCready et al. EUROPACE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
- (2010) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2010) Lewis B. Morgenstern et al. STROKE
- Assays for Measuring Rivaroxaban: Their Suitability and Limitations
- (2010) Edelgard Lindhoff-Last et al. THERAPEUTIC DRUG MONITORING
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)
- (2010) Roman Romero-Ortuno et al. BMC Geriatrics
- Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
- (2009) Riccardo Cappato et al. Circulation-Arrhythmia and Electrophysiology
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
- (2009) P. Kirchhof et al. EUROPACE
- Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
- (2009) R. D. Lopes et al. EUROPEAN HEART JOURNAL
- Role of the CHADS2Score in the Evaluation of Thromboembolic Risk in Patients With Atrial Fibrillation Undergoing Transesophageal Echocardiography Before Pulmonary Vein Isolation
- (2009) Sarinya Puwanant et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
- (2009) Rikke Sørensen et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
- (2008) P. P. Karjalainen et al. EUROPEAN HEART JOURNAL
- Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation
- (2008) R D Lopes et al. HEART
- Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation
- (2008) DANIEL SCHERR et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Bivalirudin during Primary PCI in Acute Myocardial Infarction
- (2008) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation
- (2008) Gregory Y H Lip BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now